Members-only Site   |   Print Page   |   Contact Us   |   Sign In   |   Register
News & Press: Breaking News

PCAC Meeting March 8 & 9 - Join the Live Webcast

Tuesday, March 8, 2016   (0 Comments)
Posted by: Dagmar Anderson
Share |



FDA's Pharmacy Compounding Advisory Committee meets today and tomorrow.


Today, the committee will discuss six bulk drug substances nominated for inclusion on the section 503A bulk drug substances list. FDA will discuss the following nominated bulk drug substances: quinacrine hydrochloride, boswellia, aloe vera 200:1 freeze dried, D-ribose, chondroitin sulfate, and acetyl-L-carnitine.


Tomorrow, March 9th, the committee will discuss two categories of drug products nominated for the list of drug products that present demonstrable difficulties for compounding. These categories of drug products are metered dose inhalers and dry powder inhalers.


More information about the meeting can be found here.


Click here to join the live webcast. 

Association Management Software Powered by YourMembership  ::  Legal